ArabFinance: The ordinary general meeting (OGM) of Kahira Pharmaceuticals and Chemical Industries Company (CPCI) approved the distribution of EGP 5.53 per share in cash dividends for the fiscal year (FY) 2021/2022, according to a filing to the Egyptian Exchange (EGX) on Monday.
It is worth noting that the company achieved a net profit after tax of EGP 177.077 million in FY 2021/2022, up from EGP 124.305 million the year before, as per financial indicators.
Kahira Pharmaceuticals is an Egypt-based company involved in the manufacture and trade of pharmaceutical products for human and veterinary use.